Siemens Healthcare has received FDA clearance for its Virtual Touch imaging ultrasound application.
Siemens Healthcare has received FDA clearance for its Virtual Touch imaging ultrasound application, the company announced.
This is the company’s first commercially available implementation of its Acoustic Radiation Force Impulse technology.
Virtual Touch, which uses sound beams to gently compress tissues, allows clinicians to visualize tissue stiffness, seeing deeper into the body, the company said. The technology displays a map, or elastogram, of relative tissue stiffness. The map is more uniform than manual compression techniques, the company said.
It is available on Siemens’ ACUSON S2000 and ACUSON S3000 systems. It is cleared for use in abdominal, breast, thyroid, small parts and musculoskeletal exams. The technology has been available for use in Europe and Asia since 2008.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.